Trade Summary

4 days ago, Parikh Anand Kiran, serving as President and CEO at Faeth Therapeutics, Inc. (FTH), purchased 2,806 shares at $19.76 per share, for a total transaction value of $55,446.56. Following this transaction, Parikh Anand Kiran now holds 764,234 shares of FTH.

This purchase represents a 0.37% increase in Parikh Anand Kiran's stake in the company.

The trade was executed on Monday, June 22, 2026 and publicly disclosed via SEC Form 4 filing on Wednesday, June 24, 2026 at 6:55 PM ET, 2 days after the trade was made.

Faeth Therapeutics, Inc. operates in the HEALTHCARE sector, specifically within the BIOTECHNOLOGY industry. Insider buying activity in this sector can provide valuable signals about industry trends and company-specific developments.